Daniel O'Connell is the Chief Executive Officer of Acumen Pharmaceuticals, a biopharmaceutical company focused on CNS diseases including Alzheimer's disease.
Daniel O'Connell is the Chief Executive Officer of Acumen Pharmaceuticals, a biopharmaceutical company focused on CNS diseases including Alzheimer's disease. He has over 25 years of experience building and investing in CNS companies. He led Acumen from its seed-stage origins and oversaw the company as it received FDA Fast Track designation for its Alzheimer's treatment.
Full founder directory · Investor directory · Company funding database · Fundraising library